Nukkleus (NASDAQ:DFNS) Issues Earnings Results, Misses Expectations By $177.61 EPS

Nukkleus (NASDAQ:DFNSGet Free Report) issued its earnings results on Tuesday. The company reported ($180.72) earnings per share for the quarter, missing analysts’ consensus estimates of ($3.11) by ($177.61), Zacks reports.

Nukkleus Trading Down 12.2%

NASDAQ DFNS traded down $3.79 on Tuesday, hitting $27.20. 180,118 shares of the stock were exchanged, compared to its average volume of 1,308,125. Nukkleus has a 52-week low of $3.70 and a 52-week high of $1,948.75. The company has a debt-to-equity ratio of 0.07, a current ratio of 0.25 and a quick ratio of 0.21. The company has a market capitalization of $20.67 million, a price-to-earnings ratio of -0.07 and a beta of -5.80. The company’s 50-day moving average price is $25.61 and its two-hundred day moving average price is $96.91.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on the company. Wall Street Zen downgraded Nukkleus from a “sell” rating to a “strong sell” rating in a research report on Saturday. Noble Financial upgraded Nukkleus to a “strong-buy” rating in a report on Monday, June 29th. Finally, Weiss Ratings lowered Nukkleus from a “sell (d+)” rating to a “sell (e+)” rating in a research report on Monday, July 20th. One research analyst has rated the stock with a Strong Buy rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy”.

Check Out Our Latest Research Report on Nukkleus

Institutional Trading of Nukkleus

A number of hedge funds have recently made changes to their positions in DFNS. GM Advisory Group LLC acquired a new position in Nukkleus in the 4th quarter valued at approximately $56,000. BNP Paribas Financial Markets acquired a new position in Nukkleus in the 2nd quarter worth about $56,000. Price T Rowe Associates Inc. MD acquired a new position in Nukkleus in the 4th quarter worth about $57,000. Millennium Management LLC purchased a new stake in shares of Nukkleus during the 4th quarter worth about $60,000. Finally, State Street Corp lifted its holdings in shares of Nukkleus by 70.7% during the 4th quarter. State Street Corp now owns 17,863 shares of the company’s stock valued at $72,000 after buying an additional 7,400 shares during the last quarter. 12.47% of the stock is owned by hedge funds and other institutional investors.

About Nukkleus

(Get Free Report)

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.

Featured Stories

Earnings History for Nukkleus (NASDAQ:DFNS)

Receive News & Ratings for Nukkleus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nukkleus and related companies with MarketBeat.com's FREE daily email newsletter.